New antibody drug aims to tame ulcerative colitis
NCT ID NCT06619990
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests a new antibody drug called XmAb942 for moderate-to-severe ulcerative colitis, a chronic inflammatory bowel disease. First, healthy volunteers will receive the drug to check safety. Then, about 270 people with ulcerative colitis will get either XmAb942 or a placebo to see if it can reduce symptoms and inflammation. The goal is to find a new treatment that helps patients achieve remission.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- XmAb942 (an antibody)
- What this could lead to
- If successful, this could lead to a new treatment option for people with moderate-to-severe ulcerative colitis, potentially helping them achieve remission.
- What could go wrong
- This is an early trial (phase 1/2) with a small number of participants. The drug may not work as hoped, and side effects are unknown. It will take years before it might be available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xencor Investigative Site
RECRUITINGScottsdale, Arizona, 85255, United States
-
Xencor Investigative Site
RECRUITINGBradenton, Florida, 34209, United States
-
Xencor Investigative Site
RECRUITINGBrandon, Florida, 33511, United States
-
Xencor Investigative Site
RECRUITINGJacksonville, Florida, 32258, United States
-
Xencor Investigative Site
RECRUITINGKissimmee, Florida, 34741, United States
-
Xencor Investigative Site
RECRUITINGMargate, Florida, 33063, United States
-
Xencor Investigative Site
RECRUITINGPalmetto Bay, Florida, 33176, United States
-
Xencor Investigative Site
RECRUITINGTampa, Florida, 33612, United States
-
Xencor Investigative Site
RECRUITINGTampa, Florida, 33613, United States
-
Xencor Investigative Site
RECRUITINGLouisville, Kentucky, 40218, United States
-
Xencor Investigative Site
RECRUITINGOxford, Mississippi, 38655, United States
-
Xencor Investigative Site
RECRUITINGTupelo, Mississippi, 38801, United States
-
Xencor Investigative Site
RECRUITINGAlbany, New York, 12206, United States
-
Xencor Investigative Site
RECRUITINGRochester, New York, 14618, United States
-
Xencor Investigative Site
RECRUITINGRaleigh, North Carolina, 27612, United States
-
Xencor Investigative Site
RECRUITINGBeavercreek, Ohio, 45440, United States
-
Xencor Investigative Site
RECRUITINGCordova, Tennessee, 38018, United States
-
Xencor Investigative Site
RECRUITINGCedar Park, Texas, 78613, United States
-
Xencor Investigative Site
RECRUITINGDenton, Texas, 76201, United States
-
Xencor Investigative Site
RECRUITINGGarland, Texas, 75044, United States
-
Xencor Investigative Site
RECRUITINGGeorgetown, Texas, 78628, United States
-
Xencor Investigative Site
RECRUITINGHouston, Texas, 77024, United States
-
Xencor Investigative Site
RECRUITINGHouston, Texas, 77090, United States
-
Xencor Investigative Site
RECRUITINGKingwood, Texas, 77339, United States
-
Xencor Investigative Site
RECRUITINGLubbock, Texas, 79424, United States
-
Xencor Investigative Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Xencor Investigative Site
RECRUITINGTyler, Texas, 75701, United States
-
Xencor Investigative Site
RECRUITINGWebster, Texas, 77598, United States
-
Xencor Investigative Site
RECRUITINGRichmond, Virginia, 23229, United States
-
Xencor Investigative Site
RECRUITINGBuenos Aires, C425BGC, Argentina
-
Xencor Investigative Site
RECRUITINGRosario, S2000, Argentina
-
Xencor Investigative Site
RECRUITINGSan Miguel de Tucumán, 4000, Argentina
-
Xencor Investigative Site
RECRUITINGAdelaide, 5000, Australia
-
Xencor Investigative Site
COMPLETEDJoondalup, 6027, Australia
-
Xencor Investigative Site
RECRUITINGMelbourne, 3004, Australia
-
Xencor Investigative Site
COMPLETEDNedlands, 6009, Australia
-
Xencor Investigative Site
RECRUITINGSouth Brisbane, 4101, Australia
-
Xencor Investigative Site
RECRUITINGSouthport, 4215, Australia
-
Xencor Investigative Site
RECRUITINGWollongong, 2500, Australia
-
Xencor Investigative Site
RECRUITINGCampinas, 13092-133, Brazil
-
Xencor Investigative Site
RECRUITINGPorto Alegre, 90035-903, Brazil
-
Xencor Investigative Site
RECRUITINGSanto André, 09080-110, Brazil
-
Xencor Investigative Site
RECRUITINGSão Paulo, 04543-011, Brazil
-
Xencor Investigative Site
RECRUITINGVotuporanga, 15500-269, Brazil
-
Xencor Investigative Site
RECRUITINGSofia, 1618, Bulgaria
-
Xencor Investigative Site
RECRUITINGLondon, N6K 1M5, Canada
-
Xencor Investigative Site
RECRUITINGMontreal, H3H 1EB, Canada
-
Xencor Investigative Site
RECRUITINGScarborough, M1S4T7, Canada
-
Xencor Investigative Site
RECRUITINGVancouver, V6Z 2K5, Canada
-
Xencor Investigative Site
RECRUITINGOsijek, 31000, Croatia
-
Xencor Investigative Site
RECRUITINGRijeka, 51000, Croatia
-
Xencor Investigative Site
RECRUITINGZagreb, 10000, Croatia
-
Xencor Investigative Site
RECRUITINGTbilisi, 0112, Georgia
-
Xencor Investigative Site
RECRUITINGAthens, 10676, Greece
-
Xencor Investigative Site
RECRUITINGHeraklion, 71500, Greece
-
Xencor Investigative Site
RECRUITINGThessaloniki, 54642, Greece
-
Xencor Investigative Site
RECRUITINGBudapest, 1066, Hungary
-
Xencor Investigative Site
RECRUITINGBudapest, 1136, Hungary
-
Xencor Investigative Site
RECRUITINGBudapest, 1139, Hungary
-
Xencor Investigative Site
RECRUITINGNyíregyháza, H-4405, Hungary
-
Xencor Investigative Site
RECRUITINGVác, 2600, Hungary
-
Xencor Investigative Site
RECRUITINGChisinau, Moldova
-
Xencor Investigative Site
RECRUITINGBydgoszcz, 85-079, Poland
-
Xencor Investigative Site
RECRUITINGKatowice, 40-748, Poland
-
Xencor Investigative Site
RECRUITINGKrakow, 30-363, Poland
-
Xencor Investigative Site
RECRUITINGNowy Targ, 34-400, Poland
-
Xencor Investigative Site
RECRUITINGSopot, 81-756, Poland
-
Xencor Investigative Site
RECRUITINGStaszów, 28-200, Poland
-
Xencor Investigative Site
RECRUITINGSzczecin, 71-685, Poland
-
Xencor Investigative Site
RECRUITINGWarsaw, 00-189, Poland
-
Xencor Investigative Site
RECRUITINGWarsaw, 004-501, Poland
-
Xencor Investigative Site
RECRUITINGWarsaw, 03-580, Poland
-
Xencor Investigative Site
RECRUITINGWroclaw, 52-416, Poland
-
Xencor Investigative Site
RECRUITINGWroclaw, 53-611, Poland
-
Xencor Investigative Site
RECRUITINGLoures, 2674-514, Portugal
-
Xencor Investigative Site
RECRUITINGBucharest, District 1, 01-1658, Romania
-
Xencor Investigative Site
RECRUITINGCluj-Napoca, 400006, Romania
-
Xencor Investigative Site
RECRUITINGPloieşti, 100032, Romania
-
Xencor Investigative Site
RECRUITINGTimișoara, 300002, Romania
-
Xencor Investigative Site
RECRUITINGIvano-Frankivsk, 76008, Ukraine
-
Xencor Investigative Site
RECRUITINGKyiv, 01135, Ukraine
-
Xencor Investigative Site
RECRUITINGKyiv, 02091, Ukraine
-
Xencor Investigative Site
RECRUITINGLutsk, 43005, Ukraine
-
Xencor Investigative Site
RECRUITINGLviv, 79000, Ukraine
-
Xencor Investigative Site
RECRUITINGLviv, 79010, Ukraine
-
Xencor Investigative Site
RECRUITINGLviv, 79059, Ukraine
-
Xencor Investigative Site
RECRUITINGUzhhorod, 88000, Ukraine
-
Xencor Investigative Site
RECRUITINGVinnytsia, 21009, Ukraine
-
Xencor Investigative Site
RECRUITINGVinnytsia, 21028, Ukraine
-
Xencor Investigative Site
RECRUITINGZhytomyr, 10001, Ukraine
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Can a new pill tame ulcerative colitis Flare-Ups?
- Could a new pill tame ulcerative colitis? a First-in-Human trial aims to find out
- Can a new pill tame ulcerative colitis when others fail?
- Can a pill tame ulcerative colitis? new trial seeks answers